1. Home
  2. EDIT vs TSBK Comparison

EDIT vs TSBK Comparison

Compare EDIT & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • TSBK
  • Stock Information
  • Founded
  • EDIT 2013
  • TSBK 1915
  • Country
  • EDIT United States
  • TSBK United States
  • Employees
  • EDIT N/A
  • TSBK N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • TSBK Banks
  • Sector
  • EDIT Health Care
  • TSBK Finance
  • Exchange
  • EDIT Nasdaq
  • TSBK Nasdaq
  • Market Cap
  • EDIT 269.8M
  • TSBK 248.4M
  • IPO Year
  • EDIT 2016
  • TSBK 1998
  • Fundamental
  • Price
  • EDIT $2.40
  • TSBK $33.86
  • Analyst Decision
  • EDIT Buy
  • TSBK
  • Analyst Count
  • EDIT 10
  • TSBK 0
  • Target Price
  • EDIT $4.13
  • TSBK N/A
  • AVG Volume (30 Days)
  • EDIT 2.0M
  • TSBK 10.7K
  • Earning Date
  • EDIT 11-10-2025
  • TSBK 10-30-2025
  • Dividend Yield
  • EDIT N/A
  • TSBK 3.22%
  • EPS Growth
  • EDIT N/A
  • TSBK 21.93
  • EPS
  • EDIT N/A
  • TSBK 3.67
  • Revenue
  • EDIT $46,383,000.00
  • TSBK $81,618,000.00
  • Revenue This Year
  • EDIT N/A
  • TSBK N/A
  • Revenue Next Year
  • EDIT N/A
  • TSBK N/A
  • P/E Ratio
  • EDIT N/A
  • TSBK $9.17
  • Revenue Growth
  • EDIT N/A
  • TSBK 10.07
  • 52 Week Low
  • EDIT $0.91
  • TSBK $27.51
  • 52 Week High
  • EDIT $4.54
  • TSBK $38.08
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 34.46
  • TSBK 65.70
  • Support Level
  • EDIT $2.30
  • TSBK $32.34
  • Resistance Level
  • EDIT $2.55
  • TSBK $34.86
  • Average True Range (ATR)
  • EDIT 0.20
  • TSBK 0.61
  • MACD
  • EDIT -0.00
  • TSBK 0.17
  • Stochastic Oscillator
  • EDIT 20.00
  • TSBK 92.75

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

Share on Social Networks: